Graz Endocrine Causes of Hypertension (GECOH) study: A diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism

BMC Endocrine Disorders

Volumn 9, Issue , 2009, Pages

  Pilz, Stefan ^a   Tomaschitz, Andreas ^a   Stepan, Vinzenz ^a   Obermayer Pietsch, Barbara ^a   Fahrleitner Pammer, Astrid ^a   Schweighofer, Natascha ^a   Portugaller, Horst R ^a   Sourij, Harald ^a   Dobnig, Harald ^a   Meinitzer, Andreas ^a   Pieber, Thomas R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HORMONE DETERMINATION; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 65449181980     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-9-11     Document Type: Article

References (37)

1. Funder JW Carey RM Fardella C Gomez-Sanchez CE Mantero F Stowasser M Young WF Jr Montori VM Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline J Clin Endocrinol Metab 2008, 93:3266-3281 10.1210/ jc.2008-0104 18552288
2. Rossi GP Pessina AC Heagerty AM Primary aldosteronism: An update on screening, diagnosis and treatment J Hypertens 2008, 26:613-621 10.1097/ HJH.0b013e3282f4b3e6 18327065
3. Mattsson C Young WF Jr Primary aldosteronism: Diagnostic and treatment strategies Nat Clin Pract Nephrol 2006, 2:198-208 quiz, 191 p following 230 10.1038/ncpneph0151 16932426
4. Milliez P Girerd X Plouin PF Blacher J Safar ME Mourad JJ Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J Am Coll Cardiol 2005, 45:1243-1248 10.1016/ j.jacc.2005.01.015 15837256
5. Tanabe A Naruse M Naruse K Hase M Yoshimoto T Tanaka M Seki T Demura R Demura H Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension Hypertens Res 1997, 20:85-90 10.1291/hypres.20.85 9220271
6. Sechi LA Novello M Lapenna R Baroselli S Nadalini E Colussi GL Catena C Long-term renal outcomes in patients with primary aldosteronism Jama 2006, 295:2638-2645 10.1001/jama.295.22.2638 16772627
7. Catena C Colussi G Nadalini E Chiuch A Baroselli S Lapenna R Sechi LA Cardiovascular outcomes in patients with primary aldosteronism after treatment Arch Intern Med 2008, 168:80-85 10.1001/archinternmed.2007.33 18195199
8. Strauch B Petrak O Zelinka T Wichterle D Holaj R Kasalicky M Safarik L Rosa J Widimsky J Jr Adrenalectomy improves arterial stiffness in primary aldosteronism Am J Hypertens 2008, 21:1086-1092 10.1038/ ajh.2008.243 18654122
9. Sywak M Pasieka JL Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism Br J Surg 2002, 89:1587-1593 10.1046/j.1365-2168.2002.02261.x 12445071
10. Montori VM Young WF Jr Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature Endocrinol Metab Clin North Am 2002, 31:619-632 xi 10.1016/S0889-8529(02)00013-0 12227124
11. Schirpenbach C Seiler L Maser-Gluth C Beuschlein F Reincke M Bidlingmaier M Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: Comparison to radioimmunoassays with and without extraction steps Clin Chem 2006, 52:1749-1755 10.1373/ clinchem.2006.068502 16858077
12. Mulatero P Rabbia F Milan A Paglieri C Morello F Chiandussi L Veglio F Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism Hypertension 2002, 40(6):897-902 10.1161/ 01.HYP.0000038478.59760.41 12468576
13. Seifarth C Trenkel S Schobel H Hahn EG Hensen J Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism Clin Endocrinol (Oxf) 2002, 57(4):457-465 10.1046/ j.1365-2265.2002.01613.x 12354127
14. Warnock DG Low-renin and nonmodulating essential hypertension Hypertension 1999, 34(3):395-397 10489383
15. Bossuyt PM Reitsma JB Bruns DE Gatsonis CA Glasziou PP Irwig LM Moher D Rennie D de Vet HC Lijmer JG The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration Ann Intern Med 2003, 138:W1-12 12513067
16. Mancia G De Backer G Dominiczak A Cifkova R Fagard R Germano G Grassi G Heagerty AM Kjeldsen SE Laurent S et al 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 2007, 28:1462-1536 17562668
17. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Jones DW Materson BJ Oparil S Wright JT Jr et al Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 2003, 42:1206-1252 10.1161/ 01.HYP.0000107251.49515.c2 14656957
18. Levey AS Coresh J Balk E Kausz AT Levin A Steffes MW Hogg RJ Perrone RD Lau J Eknoyan G National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification Ann Intern Med 2003, 139:137-147 12859163
19. Mosso L Carvajal C Gonzalez A Barraza A Avila F Montero J Huete A Gederlini A Fardella CE Primary aldosteronism and hypertensive disease Hypertension 2003, 42:161-165 10.1161/01.HYP.0000079505.25750.11 12796282
20. Tanabe A Naruse M Takagi S Tsuchiya K Imaki T Takano K Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism J Clin Endocrinol Metab 2003, 88:2489-2494 10.1210/jc.2002-021476 12788844
21. Mulatero P Milan A Fallo F Regolisti G Pizzolo F Fardella C Mosso L Marafetti L Veglio F Maccario M Comparison of confirmatory tests for the diagnosis of primary aldosteronism J Clin Endocrinol Metab 2006, 91:2618-2623 10.1210/jc.2006-0078 16670162
22. Diederich S Bidlingmaier M Quinkler M Reincke M [Diagnosis of primary hyperaldosteronism] Med Klin (Munich) 2007, 102:16-21 10.1007/ s00063-007-1002-y 17221347
23. Nishizaka MK Pratt-Ubunama M Zaman MA Cofield S Calhoun DA Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension Am J Hypertens 2005, 18(6):805-812 10.1016/j.amjhyper.2005.01.002 15925740
24. Schwartz GL Turner ST Screening for primary aldosteronism in essential hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity Clin Chem 2005, 51:386-394 10.1373/clinchem.2004.041780 15681560
25. Roth HJ Validation of immunoradiometric assay "RENIN III GENERATION" for the determination of active renin concentration Clin Lab 1994, 40:1007-1015
26. Turpeinen U Hamalainen E Stenman UH Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 2008, 862:113-118 10.1016/ j.jchromb.2007.11.005 18054292
27. Guo T Taylor RL Singh RJ Soldin SJ Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry Clin Chim Acta 2006, 372(1-2):76-82 10.1016/ j.cca.2006.03.034 16707118
28. Jones SR Carley S Harrison M An introduction to power and sample size estimation Emerg Med J 2003, 20:453-458 1726174 12954688 10.1136/ emj.20.5.453
29. Strauch B Zelinka T Hampf M Bernhardt R Widimsky J Jr Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region J Hum Hypertens 2003, 17:349-352 10.1038/ sj.jhh.1001554 12756408
30. Stowasser M Gordon RD Primary aldosteronism-careful investigation is essential and rewarding Mol Cell Endocrinol 2004, 217:33-39 10.1016/ j.mce.2003.10.006 15134798
31. DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach Biometrics 1988, 44:8370-845 10.2307/2531595 3203132
32. Bland JM Altman DG Measuring agreement in method comparison studies Stat Methods Med Res 1999, 8:135-160 10.1191/096228099673819272 10501650
33. Stephan C Wesseling S Schink T Jung K Comparison of eight computer programs for receiver-operating characteristic analysis Clin Chem 2003, 49:433-439 10.1373/49.3.433 12600955
34. Rossi GP Belfiore A Bernini G Desideri G Fabris B Ferri C Giacchetti G Letizia C Maccario M Mallamaci F et al Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma J Hypertens 2007, 25:1433-1442 10.1097/ HJH.0b013e328126856e 17563566
35. Connell JM MacKenzie SM Freel EM Fraser R Davies E A lifetime of aldosterone excess: Long-term consequences of altered regulation of aldosterone production for cardiovascular function Endocr Rev 2008, 29:133-154 10.1210/er.2007-0030 18292466
36. Mulatero P Verhovez A Morello F Veglio F Diagnosis and treatment of low-renin hypertension Clin Endocrinol (Oxf) 2007, 67(3):324-334 10.1111/ j.1365-2265.2007.02898.x 17573898
37. Warnock DG Bell PD Improvement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension Hypertension 2005, 46(3):469-470 10.1161/01.HYP.0000179583.64413.c1 16116049